《美國股市》英偉達再漲4%市值破2萬億美元 道指早段升逾百點
英偉達(NVDA.US)續漲帶動市場樂觀情緒持續,美股三大指數周五造好,標普500指數升至5,100的新高,道指早段漲逾100點。
標普500指數高開13.89點或0.27%,報5,100.92點;道指高開58.86點或0.15%,報39,127.97點;納指高開53.18點或0.33%,報16,094.8點。
英偉達繼周四狂飆16%後,周五早段再漲逾4%,最高見823.94美元,市值突破2萬億美元。其他晶片股偏軟,AMD(AMD.US)跌近1%,博通(AVGO.US)升0.8%。
二手車零售商Carvana(CVNA.US)因預期今年銷售上升,股價早段漲逾40%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.